1187318-52-0 Usage
General Description
3-bromo-5-fluoro-2-methylbenzoic acid is a chemical compound with the molecular formula C8H6BrFO2. It is a derivative of benzoic acid and contains a bromine atom, a fluorine atom, and a methyl group attached to a benzene ring. 3-bromo-5-fluoro-2-methylbenzoic acid is commonly used in organic synthesis and pharmaceutical research as a building block in the creation of various molecules. Its properties and structure make it valuable for introducing specific functional groups and substituents into a molecule, and it is frequently utilized in the development of new pharmaceuticals and organic compounds. Additionally, it may have potential applications in the fields of medicine and materials science due to its unique chemical structure.
Check Digit Verification of cas no
The CAS Registry Mumber 1187318-52-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,8,7,3,1 and 8 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1187318-52:
(9*1)+(8*1)+(7*8)+(6*7)+(5*3)+(4*1)+(3*8)+(2*5)+(1*2)=170
170 % 10 = 0
So 1187318-52-0 is a valid CAS Registry Number.
1187318-52-0Relevant articles and documents
SUBSTITUTED ISOINDOLINONES
-
Paragraph 0163, (2020/06/05)
Substituted isoindolinones of Formula (I), methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds to treat or ameliorate diseases, disorders, or conditions associated with protein malfunction, such as cancer, are provided.
INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL
-
Page/Page column 94, (2010/11/18)
This invention relates to compounds having structural Formula I: and pharmaceutically acceptable salts thereof which are inhibitors of the Renal Outer Medullary Potassium (ROMK) channel (Kir1.1). The compounds of Formula I are useful as diuretics and natriuretics and therefore are useful for the therapy and prophylaxis of disorders resulting from excessive salt and water retention, including cardiovascular diseases such as hypertension and chronic and acute heart failure
